MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis

Area of Science:

• Immunology
• Neuroscience
• Hepatology

Background:

• The liver-brain axis involves complex signaling pathways.
• Hepatic inflammation in metabolic dysfunction-associated steatotic liver disease (MASLD) significantly impacts systemic immunity.
• Hepatic lymphatic output is a major source of circulating T cells and cytokines.

Purpose of the Study:

• To propose T lymphocytes as key effectors in hepatosystemic inflammation.
• To elucidate the role of T cell licensing in linking liver disease to neuroinflammation.
• To identify therapeutic targets within the liver-brain immune axis.

Main Methods:

• Conceptual framework development based on existing literature.
• Analysis of immune cell trafficking and signaling pathways.
• Integration of hepatology, immunology, and neuroscience principles.

Main Results:

• Hepatosystemic inflammation, driven by liver disease, generates peripheral signals that may prime T cells for CNS entry.
• Neuroinflammatory signals at CNS barriers may facilitate T cell access.
• T cell licensing by hepatosystemic signals is proposed as the immune arm of the liver-brain axis.

Conclusions:

• T cell licensing by hepatosystemic signals bridges metabolic liver disease and neuroimmune dysfunction.
• This mechanism connects liver inflammation to cognitive decline.
• Candidate therapeutic targets along this cascade are identified for future research.